SCHEMBL17840202

SCHEMBL17840202

Cc1cccc(-c2ccccc2N(C[C@H]2CCN(C)C2)C(=O)O)c1

nearest known ligand 0.56

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
CHRM3 P20309 18/20 0.56
DRD1 P21728 1/20 0.41
HTR2A P28223 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17840221 1.00 CHRM3 (0.56) CHRM3DRD1HTR2A
SCHEMBL17840205 1.00 CHRM3 (0.56) CHRM3DRD1HTR2A
SCHEMBL17840245 0.91 CHRM3 (0.53) CHRM3
SCHEMBL17840242 0.91 CHRM3 (0.53) CHRM3
SCHEMBL17796997 0.90 CHRM3 (0.51) CHRM3
SCHEMBL17797008 0.90 CHRM3 (0.51) CHRM3
SCHEMBL17840069 0.89 CHRM3 (0.55) CHRM3
SCHEMBL17840072 0.89 CHRM3 (0.55) CHRM3
SCHEMBL17840224 0.89 CHRM3 (0.58) CHRM3
SCHEMBL17840159 0.89 CHRM3 (0.58) CHRM3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9828339-B2 Biphenyl derivatives and methods for preparing same DONG-A ST CO., LTD (KR) 2017-11-28 US disclosed
US-20160176816-A1 NOVEL BIPHENYL DERIVATIVE AND METHOD FOR PREPARING SAME DONG-A ST CO., LTD (KR) 2016-06-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160176816-A1 NOVEL BIPHENYL DERIVATIVE AND METHOD FOR PREPARING SAME CHRM2, CHRM3, CHRM5 CHRM3 2/4885DRD1 434/4885HTR2A 279/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.